Condensed Consolidated Statements of Cash Flows
(unaudited)

|  |  |  |  | Six Month Ended June 30, 2004 | Six Month Ended June 30, 2004 (as restated)
--- | --- | --- | --- | --- | --- | ---
|  | Cash flows from operating activities |  |
|  |  | Net cash used in operating activities | -16,757,000 | -49,452,000
|  |  |  | Net income (loss) | 14,021,000 | -4,295,000
|  |  |  | Depreciation and amortization | 20,222,000 | 21,951,000
|  |  |  | Asset impairment charges | 201,000 | 249,000
|  |  |  | Gain on sale of building | -896,000 |
|  |  |  | Cash used in discontinued operations | -493,000 | -977,000
|  |  |  | Changes in other assets and liabilities, net of non-cash transactions | -49,812,000 | -66,380,000
|  | Cash flows from investing activities: |  |
|  |  | Net cash used in investing activities | -3,849,000 | -12,255,000
|  |  |  | Purchase of property, plant and equipment | -11,079,000 | -13,248,000
|  |  |  | Proceeds from the sale of building | 6,731,000 |
|  |  |  | Other | 499,000 | 993,000
|  | Cash flows from financing activities: |  |
|  |  | Net cash provided by financing activities | 18,454,000 | 46,852,000
|  |  |  | Proceeds from borrowings | 101,571,000 | 144,078,000
|  |  |  | Payment of Debt | -91,801,000 | -94,289,000
|  |  |  | Proceeds from stock options exercised | 12,481,000 | 759,000
|  |  |  | Payment of dividends | -3,797,000 | -3,696,000
|  | Net decrease in cash and cash equivalents | -2,152,000 | -14,855,000
|  | Cash and Cash Equivalents--end of period | 14,858,000 | 18,026,000
|  | Cash and Cash Equivalents--beginning of period | 17,010,000 | 32,881,000

These sample instance documents and taxonomies were developed as a 'test' of the USGAAP XBRL taxonomy and certain software tools. Because the taxonomy and tools are not yet complete, the instance documents and taxonomies are not 'full'-, accurate-, representations.